CN103048445A - Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof - Google Patents
Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof Download PDFInfo
- Publication number
- CN103048445A CN103048445A CN2012105406084A CN201210540608A CN103048445A CN 103048445 A CN103048445 A CN 103048445A CN 2012105406084 A CN2012105406084 A CN 2012105406084A CN 201210540608 A CN201210540608 A CN 201210540608A CN 103048445 A CN103048445 A CN 103048445A
- Authority
- CN
- China
- Prior art keywords
- bisphenol
- lysine
- poly
- solution
- envelope antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 title claims abstract description 151
- 239000000427 antigen Substances 0.000 title claims abstract description 60
- 102000036639 antigens Human genes 0.000 title claims abstract description 60
- 108091007433 antigens Proteins 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 108010039918 Polylysine Proteins 0.000 title abstract 4
- 229920000656 polylysine Polymers 0.000 title abstract 4
- 239000000243 solution Substances 0.000 claims abstract description 34
- 238000002965 ELISA Methods 0.000 claims abstract description 17
- VKOUCJUTMGHNOR-UHFFFAOYSA-N Diphenolic acid Chemical compound C=1C=C(O)C=CC=1C(CCC(O)=O)(C)C1=CC=C(O)C=C1 VKOUCJUTMGHNOR-UHFFFAOYSA-N 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 238000005859 coupling reaction Methods 0.000 claims abstract description 10
- 230000008878 coupling Effects 0.000 claims abstract description 9
- 238000010168 coupling process Methods 0.000 claims abstract description 9
- 239000000758 substrate Substances 0.000 claims abstract description 8
- 239000012086 standard solution Substances 0.000 claims abstract description 7
- 102000014914 Carrier Proteins Human genes 0.000 claims abstract description 5
- 108010078791 Carrier Proteins Proteins 0.000 claims abstract description 5
- 239000007790 solid phase Substances 0.000 claims abstract description 5
- 239000003085 diluting agent Substances 0.000 claims abstract description 3
- 229940106691 bisphenol a Drugs 0.000 claims description 63
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims description 38
- 239000007788 liquid Substances 0.000 claims description 22
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 13
- 239000008055 phosphate buffer solution Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004472 Lysine Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 230000001900 immune effect Effects 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 claims description 2
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 2
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims 1
- 238000008157 ELISA kit Methods 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000010189 synthetic method Methods 0.000 abstract description 4
- 238000002203 pretreatment Methods 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 abstract description 2
- 239000012089 stop solution Substances 0.000 abstract 1
- 239000012224 working solution Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 17
- 238000011534 incubation Methods 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- 230000036039 immunity Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 230000002860 competitive effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 238000002211 ultraviolet spectrum Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010058846 Ovalbumin Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940092253 ovalbumin Drugs 0.000 description 3
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- KLSLBUSXWBJMEC-UHFFFAOYSA-N 4-Propylphenol Chemical compound CCCC1=CC=C(O)C=C1 KLSLBUSXWBJMEC-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000004715 cellular signal transduction Effects 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000003360 nephrocyte Anatomy 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000005477 standard model Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The present invention discloses a preparation method of bisphenol A-coated antigen with polylysine as a carrier and application thereof, is aimed at providing the preparation method of bisphenol A-coated antigen with polylysine as the carrier which is simple in the synthetic method and the application thereof, and finally establishes an enzyme linked immunosorbent assay kit. The kit has the advantages of simple pre-treatment, fast speed and accuracy and low cost, and can be used for on-site testing in large scale. The technical points include: taking polylysine as a carrier protein, preparing bisphenol A-coated antigen by coupling with diphenolic acid, and applying the bisphenol A-coated antigen to prepare the bisphenol A enzyme linked immunosorbent assay kit, wherein the bisphenol A enzyme linked immunosorbent assay kit is composed of a solid phase carrier of envelope antigen, an antibody working solution, a bisphenol A standard solution, an enzyme labeled secondary antibody solution, an antibody diluent, a wash concentrated solution, a substrate solution and a stop solution. The preparation method belongs to the technical field of enzyme linked immunoassay.
Description
Technical field
The present invention relates to poly-D-lysine is bisphenol-A envelope antigen preparation method and the application thereof of carrier, belongs to the Enzyme-multiplied immune technique field.
Background technology
Bisphenol-A (Bisphenol A, BPA) be 2, two (4-hydroxy phenyl) propane of 2-imitate or disturb endogenous estrogen action by being combined with estrogen receptor or affecting the mode such as cellular signal transduction approach in vivo, and Person's skin, respiratory tract, alimentary canal and cornea are had pungency.When the bisphenol-A in the body reaches a certain amount of, will destroy liver cell and nephrocyte, cause slow poisoning, make the people in various degree symptoms such as giddy, headache, fash, spiritual uneasiness and diarrhoea occur.In recent years, the bisphenol-A of all finding the estrogen similar effect all over the world in barreled drinking water, baby bottles and the various water body exists that (Science. 2007,317 (5840): 884-885), because instrument analytical method is not suitable with on-the-spot and fast bisphenol-A in barreled drinking water and the baby bottles is detected, and immunoassay reacts based on the specific binding between Ag-Ab, selectivity is good, by selecting suitable mark system, can realize the rapid sensitive of trace materials in the complex system is detected.Enzyme-linked immune analytic method is highly sensitive, high specificity, quick, economic, is fit to very much the residual screening of BPA and detects.
Study the enzyme-linked immune analytic method of bisphenol-A, at first must prepare the antibody of bisphenol-A.Bisphenol-A is micromolecular compound, and is simple in structure, can not produce antibody by the direct immunization animal, must first itself and carrier protein coupling be prepared comlete antigen, utilizes immunizing antigen injection animal to bring out generation antibody.Method commonly used is to utilize classical carbodlimide method or glutaraldehyde method at present, and selecting bovine serum albumin(BSA) or ovalbumin is that carrier comes the synthesis of bisphenol A artificial antigen.Application number is in 200810234850.2 the patent, and the petty official is transmitted etc. and to have been introduced take diphenolic acid as haptens and the OVA coupling prepares the method for envelope antigen.Poly-l-lysine (PLL) is a kind of artificial synthetic polypeptide, autoimmunity originality is very poor but can increase haptenic immunity, and has more free amino group, can greatly improve carrier protein and haptenic coupling rate, so recent years is the disclosed method for preparing melamine complete antigen take poly-D-lysine as carrier in 200810051488.5 by in the increasing preparation in order to artificial immunity antigen such as China Patent No.; The Chinese patent patent No. 200610041918.6 provides the new synthetic method of ivermectin artificial antigen.But be showed no the patent for preparing the artificial envelope antigen of bisphenol-A take poly-D-lysine as carrier.
Summary of the invention
For above-mentioned deficiency, the object of the present invention is to provide simply bisphenol-A envelope antigen preparation method and the application thereof take poly-D-lysine as carrier of a kind of synthetic method, and finally set up the enzyme linked immunological kit that bisphenol-A detects.
For solving the problems of the technologies described above, last technical scheme of the present invention is such: a kind of bisphenol-A envelope antigen preparation method and application thereof take poly-D-lysine as carrier take poly-D-lysine as carrier protein, prepares the bisphenol-A envelope antigen with the diphenolic acid coupling.
Above-mentioned bisphenol-A envelope antigen preparation method and application thereof take poly-D-lysine as carrier comprise the steps: 1 successively) be dissolved in diphenolic acid in the organic solvent fully; 2) be dissolved in respectively NHS (N-hydroxy-succinamide) and EDCHCL in the machine solvent fully; 3) with step 2) solution that makes drops in the solution that step 1) makes, and the room temperature lucifuge stirs 1-24h, and centrifuging is got supernatant and is got A liquid; 4) poly-D-lysine is dissolved in one-tenth B liquid in the phosphate buffer solution; 5) the A drop with the step 3) preparation adds in the B liquid, and the room temperature lucifuge stirs 1-24h, centrifuging, supernatant is transferred to bag filter, with the phosphate buffer solution 24-96h that dialyses, per 12 h change dislysate one time, and at last dislysate being obtained the artificial envelope antigen of bisphenol-A through freeze drying is BVA-PLL;
Wherein: the mol ratio of diphenolic acid and NHS, EDCHCL, poly-D-lysine is: 30～200 ﹕, 30～400 ﹕, 30～400 ﹕ 1.
Further, above-mentioned bisphenol-A envelope antigen preparation method and application thereof take poly-D-lysine as carrier, described poly-D-lysine is poly-l-lysine or poly dextrorotation lysine or poly-l-lysine and poly dextrorotation lysine mixing use.
Further, above-mentioned bisphenol-A envelope antigen preparation method and application thereof take poly-D-lysine as carrier, it is characterized in that step 1) and step 2) described organic solvent is one of them of tetrahydrofuran or DMF or dimethyl sulfoxide (DMSO).
Further, above-mentioned bisphenol-A envelope antigen preparation method and application thereof take poly-D-lysine as carrier, the pH value of step 4) and the described phosphate buffer solution of step 5) is 6-8.
A technical scheme is such after of the present invention: use the bisphenol-A envelope antigen as the bisphenol-A enzyme-linked immunologic detecting kit, described bisphenol-A enzyme-linked immunologic detecting kit is comprised of solid phase carrier, antibody working fluid, bisphenol-A standard solution, ELIAS secondary antibody solution, antibody diluent, concentrated solution for washing, substrate solution and the stop buffer of envelope antigen;
Wherein: described solid phase carrier is the 96 hole polystyrene ELISA Plate that are coated with diphenolic acid and poly-l-lysine conjugate, and has sealed the site that micropore surface does not adsorb bisphenol-A antigen; The concentration of described bisphenol-A standard solution is respectively: 0ng/mL, 3ng/mL, 8ng/mL, 25ng/mL, 75ng/mL, 224ng/mL, 673ng/mL, 2018ng/mL.
Further, the application of the above-mentioned bisphenol-A envelope antigen take poly-D-lysine as carrier is characterized in that described antibody working fluid is the antibody of rabbit source Anti-TNF-α bisphenol-A.
Further, the application of the above-mentioned bisphenol-A envelope antigen take poly-D-lysine as carrier is characterized in that, described substrate solution is the pH5.0 phosphoric acid citric acid solution that contains tetramethyl benzidine and hydrogen peroxide; Described stop buffer is the 2mol/L sulfuric acid solution.
Further, the application of the above-mentioned bisphenol-A envelope antigen take poly-D-lysine as carrier is characterized in that, described concentrated solution for washing is that 10X contains 5% Tween-20, pH7.0, and concentration is the phosphate buffer of 0.01mol/L.
Further, the application of the above-mentioned bisphenol-A envelope antigen take poly-D-lysine as carrier is characterized in that described ELIAS secondary antibody solution is goat-anti rabbit-horseradish peroxidase.
Compared with prior art, the present invention has following advantage:
1, the advantage of antigen synthetic method: of the present invention synthetic take poly-D-lysine as carrier, the poly-D-lysine wide material sources, low price, soluble in water; In organic solvent chemical coupling process, poly-D-lysine can keep its structural stability, changeableness not, and the envelope antigen after synthetic has well solubility; The number of amino groups that contains on the poly-D-lysine much larger than albumin class material commonly used (such as chicken ovalbumin, bovine serum albumin(BSA) etc.), these functional groups can with more hapten molecule coupling, and then increased the coupling rate of molecule, be conducive to coupling reaction; Poly-D-lysine is simple in structure, can effectively reduce nonspecific reaction, improves the performance of kit; Coated carrier (chicken ovalbumin) commonly used belongs to biomacromolecule, have complicated three-dimensional structure, when its synthetic envelope antigen contacts with ELISA Plate generation hydrophobicity, deformation easily occurs in envelope antigen, little molecule haptens is shielded by macro-molecular protein, and then be unfavorable for hapten molecule presenting on ELISA Plate, yet synthetic poly-D-lysine belongs to reticulate texture, overcome this shortcoming, can more be conducive to haptens and present in ELISA Plate, improve the specific recognition between envelope antigen and the antibody;
2, be coated on the polystyrene ELISA Plate by finite concentration by synthetic envelope antigen, and with it, use the ovalbumin sealing, prepared the elisa plate bar that can directly apply to enzyme-linked immuno assay; By the bisphenol-A antibody for preparing, set up the kit using method of measuring bisphenol A residues.
3, the present invention can be used for the detection of bisphenol-A in surface water, underground water and the potable water, have pre-treatment simply, quick and precisely, with low cost, can be used for the advantages such as on-the-spot mass detection, and lowest detection is limited to 0.5ng/ml.
Description of drawings
Fig. 1 is the ultraviolet spectrum of BVA, PLL and PLL-BVA
Fig. 2 is that the indirect competitive ELISA method detects bisphenol-A competition inhibition curve;
Bisphenol-A with series concentration (2048ng/mL, 512ng/mL, 128ng/mL, 32ng/mL, 8ng/mL, 2ng/mL, 0.5ng/mL, 0.125ng/mL and 0.0312 ng/mL) carries out indirect competitive ELISA method mensuration, the standard working curve of foundation.
Embodiment
Below in conjunction with the drawings and specific embodiments claim of the present invention is described in further details, but do not consist of any limitation of the invention, the modification of the limited number of time that anyone makes in claim scope of the present invention is still in claim scope of the present invention.
1, the bisphenol-A artificial antigen is synthetic
Embodiment 1
Taking by weighing diphenolic acid (BVA) 61mg is dissolved among the 2mLDMF; Take by weighing again 30.6mgNHS and 53.2mg EDCHCL is dissolved in respectively the 2mL(tetrahydrofuran) among the DMF, slowly be added drop-wise in the BVA solution, after the room temperature lucifuge stirred 24h, centrifuging was got supernatant and is got A liquid.
Take by weighing and become B liquid in the phosphate buffer solution that the 126mg poly-l-lysine is dissolved in 5 mL pH=7, getting A liquid 4mL slowly drips in the B liquid, the room temperature lucifuge stirs 24h, centrifuging, supernatant is transferred to bag filter, with the phosphate buffer solution of pH=7.4 72 h that dialyse, per 12 h change dislysate one time, at last dislysate being obtained the artificial envelope antigen of bisphenol-A through freeze drying is PLL-BVA, identifies its structure through ultraviolet spectrum, consults Fig. 1.
Embodiment 2
Taking by weighing diphenolic acid (BVA) 20.7mg is dissolved among the 1mLDMF; Take by weighing again 6.6mgNHS and 14.2mg EDCHCL is dissolved in respectively the 1mL(tetrahydrofuran) among the DMF, slowly be added drop-wise in the BVA solution, after the room temperature lucifuge stirred 2h, centrifuging was got supernatant and is got A liquid.
Take by weighing and become B liquid in the phosphate buffer solution that 30.2mg poly mixing lysine is dissolved in 5 mL pH=7, getting A liquid 3mL slowly drips in the B liquid, the room temperature lucifuge stirs 2h, centrifuging, supernatant is transferred to bag filter, with the phosphate buffer solution of pH=7.4 72 h that dialyse, per 12 h change dislysate one time, at last dislysate being obtained the artificial envelope antigen of bisphenol-A through freeze drying is PLL-BVA, identifies its structure through ultraviolet spectrum, consults Fig. 1.
Embodiment 3
Taking by weighing diphenolic acid (BVA) 24mg is dissolved among the 1mLDMF; Take by weighing again 10mg NHS and 17.2mg EDCHCL is dissolved in respectively the 1mL(tetrahydrofuran) among the DMF, slowly be added drop-wise in the BVA solution, after the room temperature lucifuge stirred 12h, centrifuging was got supernatant and is got A liquid.
Take by weighing and become B liquid in the phosphate buffer solution that the 15mg poly-l-lysine is dissolved in 5 mL pH=7, getting A liquid 2mL slowly drips in the B liquid, the room temperature lucifuge stirs 12h, centrifuging, supernatant is transferred to bag filter, with the phosphate buffer solution of pH=7.4 72 h that dialyse, per 12 h change dislysate one time, at last dislysate being obtained the artificial envelope antigen of bisphenol-A through freeze drying is PLL-BVA, identifies its structure through ultraviolet spectrum, consults Fig. 1.
The selection bovine serum albumin(BSA) is carrier, utilizes to prepare immunizing antigen with method and diphenolic acid coupling.
2, the antibody of anti-bisphenol A preparation
With PBS lytic immunity antigen BSA-BVA, be mixed with 1mg/mL solution.Get mentioned solution 0.5mL and the equal-volume Freund's complete adjuvant is emulsified into the Water-In-Oil state, the female new zealand rabbit of 2-3kg is carried out immunity.For the first time immunity was used Freunds incomplete adjuvant per two all immunity instead once after one month, immunity 5 times, and last immunity was got the blood purifying after 15 days.
Indirect elisa method is measured tiring of immune serum.(1) coated: with coated damping fluid CBS envelope antigen (PLL-BVA) is diluted to finite concentration, joins in the 96 hole ELISA Plate with 100 μ L/ holes, 4 ℃ of coated spending the night dry liquid in the hole, and PBST washs once, and thieving paper pats dry.(2) sealing: 30mg/mL ovalbumin (PBS dissolving) 200 μ L/ holes join in the hole 37 ℃ of incubation 1h.(3) dry liquid in the hole, PBST washing three times, thieving paper pats dry.(4) add immune serum: with PBS dilution immune serum, the certain concentration doubling dilution, 100 μ L/ holes are added in the hole, establish simultaneously each 2 hole of negative control and blank.Behind 37 ℃ of incubation 1h, washing pats dry.(5) add ELIAS secondary antibody: to certain concentration, 100 μ L/ holes are added in the hole with PBS dilution ELIAS secondary antibody, and behind 37 ℃ of incubation 1h, washing pats dry.(6) colour developing and termination: preparation substrate buffer solution 10mL adds 10 μ L, 30% hydrogen peroxide, fully mixing.100 μ L/ holes are added in the hole behind the incubation 15min, 2M sulfuric acid 50 μ L/ hole cessation reactions.(7) reading: the optical density value (OD value) of measuring dual wavelength 490nm and 630nm place with microplate reader.If sample well OD value is namely positive more than or equal to 2.1 times of blank hole.
Envelope antigen concentration and optimum antibody working concentration that the screening of chessboard titrimetry is suitable adopt the indirect competitive ELISA method to detect the competition inhibiting rate of immune serum.
Detect by animal immune and serum, obtain the antibody of anti-bisphenol A.
3, the foundation of bisphenol-A ELISA standard working curve and detectability determines
With the coated 96 hole ELISA Plate of the PLL-BVA of suitable concentration, 100 μ L/ holes, 4 ℃ of coated spending the night of refrigerator pat dry with washing after the confining liquid sealing; In enzyme mark bar, each concentration BPA standard solution (0ng/mL, 3ng/mL, 8ng/mL of adding first 50 μ L, 25ng/mL, 75ng/mL, 224ng/mL, 673ng/mL, 2018ng/mL), add again the antibody of 50 μ L suitable concentrations, mix, in the blank hole, add 100 μ L10% methyl alcohol PBS damping fluids; 37 ℃ of constant temperature incubation 40min; Wash three times, pat dry; Add 100 μ L ELIAS secondary antibody working fluids, 37 ℃ of constant temperature incubation 40min; Wash three times, pat dry; Every hole adds the colour developing of 100 μ L substrate solutions, adds 50 μ L stop buffer cessation reactions behind 37 ℃ of incubation lucifuge reaction 15min, shakes up, and reads optical density value in 15 minutes.
With inhibiting rate B/B
0Be ordinate, bisphenol-A concentration BPA (ngmL
-1) make typical curve, its IC for horizontal ordinate
50Be 14.5ng/ml, lowest detection is limited to 0.5ng/ml, consults Fig. 2.
4, the specific mensuration of bisphenol-A ELISA kit
Adopt the indirect competitive ELISA method to measure the cross reaction of structure of bisphenol A analog (diphenolic acid, phenol, benzene, m-cresol and p-dihydroxy-benzene) and mixtures of antibodies.The above-mentioned substance of series concentration (1 ng/mL, 10 ng/mL, 100 ng/mL, 1 ug/mL, 10 ug/mL, 100 ug/mL, 1mg/mL, 10 mg/mL) is joined in the good ELISA Plate of coated sealing simultaneously with antibody respectively.Utilize antiserum to the IC of bisphenol-A
50Value and the IC of antiserum to each analog
50The ratio of value obtains cross reacting rate (CR%), and the cross reaction measurement result is as follows:
Bisphenol-A-100%, diphenolic acid-121%, phenol, benzene, m-cresol and p-dihydroxy-benzene are all＜0.01.Experimental result shows that this method has good specificity to bisphenol-A.
5, the using method of this kit
Step is as follows:
(1) sample pre-treatments;
Water sample is processed: aqueous sample is made into 10% methyl alcohol-PBS solution for detection of, example: get 0.8 mL water sample, add the methyl alcohol of 0.1 mL, add the 10X PBS solution of 0.1 mL after concentrated again.(when muddy such as water sample, but centrifugal 10 minutes of 15000rpm, it is to be measured to get supernatant).
(2) use kit to detect:
1. take out kit in refrigerator, the room temperature rewarming is noted must shaking up before every kind of liquid reagent uses.Get microwell plate, three hole Parallel testings are recommended to carry out in the position of the blank control wells of mark, standard model, sample in advance.
2. in enzyme mark bar, add first each concentration BPA standard solution of 50 μ L, add again 50 μ L antibody working fluids, mix, in the blank hole, add 100 μ L10% methyl alcohol PBS damping fluids.
3. in enzyme mark bar, add first 50 μ L sample solutions, add again 50 μ L antibody working fluids, mix, with 2. in enzyme mark bar jointly in 37 ℃ of constant temperature incubation 40min, microwell plate applies film.
4. incubation complete after, remove film the solution in the micropore got rid of in the tank fast, with cleansing solution (10X concentrate distilled water diluting) cleaning microwell plate.
5. add 100 μ L ELIAS secondary antibody working fluids in whole holes, 37 ℃ of constant temperature incubation 40min.
6. step is with 4., pats dry in thieving paper after wash three times, and every hole adds the colour developing of 100 μ L substrate solutions, and 37 ℃ of incubation lucifuges are reacted 15min.
7. every hole adds 50 μ L stop buffer cessation reactions, shakes up, and reads optical density value in 15 minutes.
8. measure the optical density value (OD value) at dual wavelength 450nm and 630nm place in microplate reader.
6, bisphenol-A ELISA kit accuracy determination
Add the bisphenol-A of 15 ng/mL, 100 ng/mL and 250 ng/mL in tap water, the Pearl River water water sample, triplicate, do at every turn three parallel, adopt the indirect competitive ELISA method to measure B/B0, calculate recovery rate, the result is respectively: 109.2%, 90.5%, 95.9% and 104.3%, 87.6% and 100%.
Claims (10)
1. bisphenol-A envelope antigen preparation method and the application thereof take poly-D-lysine as carrier is characterized in that, take poly-D-lysine as carrier protein, prepares the bisphenol-A envelope antigen with the diphenolic acid coupling.
2. bisphenol-A envelope antigen preparation method and the application thereof take poly-D-lysine as carrier according to claim 1 is characterized in that, comprises the steps: successively 1) be dissolved in diphenolic acid in the organic solvent fully; 2) be dissolved in respectively NHS and EDCHCL in the machine solvent fully; 3) with step 2) solution that makes drops in the solution that step 1) makes, and the room temperature lucifuge stirs 1-24h, and centrifuging is got supernatant and is got A liquid; 4) poly-D-lysine is dissolved in one-tenth B liquid in the phosphate buffer solution; 5) the A drop with the step 3) preparation adds in the B liquid, and the room temperature lucifuge stirs 1-24h, centrifuging, supernatant is transferred to bag filter, with the phosphate buffer solution 24-96h that dialyses, per 12 h change dislysate one time, and at last dislysate being obtained the artificial envelope antigen of bisphenol-A through freeze drying is BVA-PLL;
Wherein: the mol ratio of diphenolic acid and NHS, EDCHCL, poly-D-lysine is: 30～200 ﹕, 30～400 ﹕, 30～400 ﹕ 1.
3. bisphenol-A envelope antigen preparation method and the application thereof take poly-D-lysine as carrier according to claim 1 and 2, its spy is being that described poly-D-lysine is poly-l-lysine or poly dextrorotation lysine or poly-l-lysine and poly dextrorotation lysine mixing use.
4. bisphenol-A envelope antigen preparation method and the application thereof take poly-D-lysine as carrier according to claim 2, its spy is being, step 1) and step 2) described organic solvent is one of them of tetrahydrofuran or DMF or dimethyl sulfoxide (DMSO).
5. bisphenol-A envelope antigen preparation method and the application thereof take poly-D-lysine as carrier according to claim 2, its spy is being that the pH value of step 4) and the described phosphate buffer solution of step 5) is 6-8.
6. the application of the bisphenol-A envelope antigen take poly-D-lysine as carrier claimed in claim 1, it is characterized in that, use the bisphenol-A envelope antigen as the bisphenol-A enzyme-linked immunologic detecting kit, described bisphenol-A enzyme-linked immunologic detecting kit is comprised of solid phase carrier, antibody working fluid, bisphenol-A standard solution, ELIAS secondary antibody solution, antibody diluent, concentrated solution for washing, substrate solution and the stop buffer of envelope antigen;
Wherein: described solid phase carrier is the 96 hole polystyrene ELISA Plate that are coated with diphenolic acid and poly-l-lysine conjugate, and has sealed the site that micropore surface does not adsorb bisphenol-A antigen; The concentration of described bisphenol-A standard solution is respectively: 0ng/mL, 3ng/mL, 8ng/mL, 25ng/mL, 75ng/mL, 224ng/mL, 673ng/mL, 2018ng/mL.
7. the application of the bisphenol-A envelope antigen take poly-D-lysine as carrier according to claim 6 is characterized in that, described antibody working fluid is the antibody of rabbit source Anti-TNF-α bisphenol-A.
8. the application of the bisphenol-A envelope antigen take poly-D-lysine as carrier according to claim 6 is characterized in that, described substrate solution is the pH5.0 phosphoric acid citric acid solution that contains tetramethyl benzidine and hydrogen peroxide; Described stop buffer is the 2mol/L sulfuric acid solution.
9. the application of the bisphenol-A envelope antigen take poly-D-lysine as carrier according to claim 6 is characterized in that, described concentrated solution for washing is that 10X contains 5% Tween-20, pH7.0, and concentration is the phosphate buffer of 0.01mol/L.
10. the application of the bisphenol-A envelope antigen take poly-D-lysine as carrier according to claim 6 is characterized in that, described ELIAS secondary antibody solution is goat-anti rabbit-horseradish peroxidase.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210540608.4A CN103048445B (en) | 2012-12-14 | 2012-12-14 | Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210540608.4A CN103048445B (en) | 2012-12-14 | 2012-12-14 | Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103048445A true CN103048445A (en) | 2013-04-17 |
| CN103048445B CN103048445B (en) | 2015-02-04 |
Family
ID=48061159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210540608.4A Active CN103048445B (en) | 2012-12-14 | 2012-12-14 | Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103048445B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104101702A (en) * | 2014-07-04 | 2014-10-15 | 中国海洋大学 | Indirect competition ELISA (enzyme-linked immunosorbent assay method) for tetrabromo bisphenol A |
| CN105137064A (en) * | 2015-07-24 | 2015-12-09 | 中国人民大学 | Method of modifying bio-sensing component with small molecular organic substance |
| CN106153928A (en) * | 2016-07-06 | 2016-11-23 | 广东工业大学 | A kind of bisphenol-A immunity test strip containing bisphenol-A immunological probe and application thereof |
| CN107176997A (en) * | 2017-06-08 | 2017-09-19 | 广东工业大学 | A kind of C peptides immunizing antigen and anti-C peptides Yolk antibody and its preparation and application |
| CN107703294A (en) * | 2017-10-12 | 2018-02-16 | 华派生物工程集团有限公司 | A kind of ELISA method for being used to detect cLHRH antibody titers in chicken serum |
| CN111239383A (en) * | 2020-01-23 | 2020-06-05 | 武汉伊莱瑞特生物科技股份有限公司 | Coating liquid and application thereof in ELISA |
| CN111521775A (en) * | 2020-04-14 | 2020-08-11 | 天津科技大学 | Method for preparing paper-based micro-fluidic chip for bisphenol A detection based on wax-spraying printing technology |
| CN112180102A (en) * | 2020-09-29 | 2021-01-05 | 郑州安图生物工程股份有限公司 | Peanut allergen specificity IgE quantitative detection reagent, kit and application thereof |
| CN112213481A (en) * | 2020-08-13 | 2021-01-12 | 茅台学院 | Hapten directly coated bisphenol A ABC enzyme-linked immunosorbent assay method based on monoclonal antibody |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101029067A (en) * | 2006-03-01 | 2007-09-05 | 中国农业科学院兰州畜牧与兽药研究所 | Synthesis of ivermectin artificial antigen |
| KR100841778B1 (en) * | 2007-02-09 | 2008-06-27 | 부산대학교 산학협력단 | Potentiometric immunosensor for detecting bisphenol a and detecting method using the same |
| US20110262306A1 (en) * | 2010-04-23 | 2011-10-27 | Industrial Technology Research Institute | Detecting apparatus with photonic crystal structure |
| KR20120095111A (en) * | 2011-02-18 | 2012-08-28 | 부산대학교 산학협력단 | Microchip for detecting trace phenolic endocrine disruptors and detection method using the same |
-
2012
- 2012-12-14 CN CN201210540608.4A patent/CN103048445B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101029067A (en) * | 2006-03-01 | 2007-09-05 | 中国农业科学院兰州畜牧与兽药研究所 | Synthesis of ivermectin artificial antigen |
| KR100841778B1 (en) * | 2007-02-09 | 2008-06-27 | 부산대학교 산학협력단 | Potentiometric immunosensor for detecting bisphenol a and detecting method using the same |
| US20110262306A1 (en) * | 2010-04-23 | 2011-10-27 | Industrial Technology Research Institute | Detecting apparatus with photonic crystal structure |
| KR20120095111A (en) * | 2011-02-18 | 2012-08-28 | 부산대학교 산학협력단 | Microchip for detecting trace phenolic endocrine disruptors and detection method using the same |
Non-Patent Citations (1)
| Title |
|---|
| ZHAO MP ET AL.: "A new competitive enzyme-linked immunosorbent assay (ELISA) for determination of estrogenic bisphenols", 《TALANTA》 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104101702A (en) * | 2014-07-04 | 2014-10-15 | 中国海洋大学 | Indirect competition ELISA (enzyme-linked immunosorbent assay method) for tetrabromo bisphenol A |
| CN104101702B (en) * | 2014-07-04 | 2016-04-20 | 中国海洋大学 | A kind of indirect competitive enzyme-linked immunosorbent detection method of tetrabromobisphenol A |
| CN105137064A (en) * | 2015-07-24 | 2015-12-09 | 中国人民大学 | Method of modifying bio-sensing component with small molecular organic substance |
| CN106153928A (en) * | 2016-07-06 | 2016-11-23 | 广东工业大学 | A kind of bisphenol-A immunity test strip containing bisphenol-A immunological probe and application thereof |
| CN107176997A (en) * | 2017-06-08 | 2017-09-19 | 广东工业大学 | A kind of C peptides immunizing antigen and anti-C peptides Yolk antibody and its preparation and application |
| CN107703294A (en) * | 2017-10-12 | 2018-02-16 | 华派生物工程集团有限公司 | A kind of ELISA method for being used to detect cLHRH antibody titers in chicken serum |
| CN107703294B (en) * | 2017-10-12 | 2019-06-04 | 华派生物工程集团有限公司 | It is a kind of for detecting the ELISA method of cLHRH antibody titer in chicken serum |
| CN111239383A (en) * | 2020-01-23 | 2020-06-05 | 武汉伊莱瑞特生物科技股份有限公司 | Coating liquid and application thereof in ELISA |
| CN111521775A (en) * | 2020-04-14 | 2020-08-11 | 天津科技大学 | Method for preparing paper-based micro-fluidic chip for bisphenol A detection based on wax-spraying printing technology |
| CN112213481A (en) * | 2020-08-13 | 2021-01-12 | 茅台学院 | Hapten directly coated bisphenol A ABC enzyme-linked immunosorbent assay method based on monoclonal antibody |
| CN112180102A (en) * | 2020-09-29 | 2021-01-05 | 郑州安图生物工程股份有限公司 | Peanut allergen specificity IgE quantitative detection reagent, kit and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103048445B (en) | 2015-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103048445B (en) | Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof | |
| CN101776685B (en) | Enzyme linked immunosorbent assay kit for detecting trimethoprim medicament and application thereof | |
| CN101363850A (en) | Melamine rapid immune detecting kit | |
| CN102353775B (en) | Immunochromatographic test strip for detecting malachite green (MG) and preparation process thereof | |
| CN102206270B (en) | Saxitoxin artificial antigen and anti-saxitoxin antibody, their preparation methods and application | |
| CN105181957A (en) | Bisphenol S detection kit, preparation method and usage method | |
| CN101526525B (en) | Enzyme-linked immunosorbent assay kit suitable for pentachlorophenol residual analysis | |
| CN101830980B (en) | Chlorothalonil antigen, antibody preparation method and residual chlorothalonil ELISA (Enzyme-Linked Lmmuno Sorbent Assay) detection method | |
| CN101538307A (en) | Dehydroepiandrosterone hapten, artificial antigen and antibody as well as preparation method and application thereof | |
| CN108535486A (en) | A kind of chloramphenicol immunofluorescence assay method based on europium label | |
| CN104387431A (en) | Preparation method of high-specificity ribavirin artificial antigens | |
| CN102539790A (en) | Enzyme-linked immunoassay kit for biotin | |
| CN101671391A (en) | Rhodamine B artificial antigen and preparation method and application thereof | |
| CN105399639A (en) | Tyramine artificial antigen and antibody, and preparation methods and application thereof | |
| CN102336814B (en) | Polypeptide sequence for preparing anti-liver-neoplasm marker CK-19 antibody, polyclonal antibody and application thereof | |
| CN101857637A (en) | Anti-norfloxacin polyclonal antibody and preparation method and application | |
| CN103102319B (en) | Melamine hapten and its preparation method and application | |
| CN105296520B (en) | A kind of preparation method and its enzyme-linked immunologic detecting kit of human tumor antigen 3H11Ag | |
| CN103145633B (en) | Novel melamine antigen and antibody and application | |
| CN102653560A (en) | Method for preparing polychlorinated biphenyl resistant polyclonal antibody | |
| CN101424685A (en) | ELISA kit for detecting melamine and method | |
| CN111377888B (en) | Rhododendrin mollis toxin III hapten as well as preparation method and application thereof | |
| CN110117286B (en) | Heterocyclic amine 8-MeIQx hapten and antibody as well as preparation method and application thereof | |
| Dzantiev et al. | Lateral flow immunoassay for bisphenol A: Development of test strips and their application for ecological monitoring | |
| CN103163302B (en) | Oligopeptide antibody kit prepared by directional cross-coupling technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130417 Assignee: SHENZHEN LVSHIYUAN BIOTECHNOLOGY Co.,Ltd. Assignor: Guangdong University of Technology Contract record no.: 2015440020367 Denomination of invention: Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof Granted publication date: 20150204 License type: Exclusive License Record date: 20151202 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Jing Inventor after: Ning Bo Inventor after: Jiang Yongqing Inventor before: Zhao Suqing Inventor before: Zhou Jianqing Inventor before: Zhang Lei Inventor before: Zhang Kun Inventor before: Zhou Lihua |
|
| COR | Change of bibliographic data | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151230 Address after: 518120, Guangdong province Shenzhen Dapeng New Area Dapeng office, new community community new Village Industrial Avenue 2, building D, 101, 201, 301 Patentee after: SHENZHEN LVSHIYUAN BIOTECHNOLOGY Co.,Ltd. Address before: 510006, Guangdong, Guangzhou, Panyu District Province, Guangzhou University, No. 100 West Ring Road, Guangdong University of engineering, room four, room 706 Patentee before: Guangdong University of Technology |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method and application of bisphenol A coated antigen using polylysine as carrier Granted publication date: 20150204 Pledgee: Shenzhen Rural Commercial Bank Co.,Ltd. Dapeng Branch Pledgor: SHENZHEN LVSHIYUAN BIOTECHNOLOGY Co.,Ltd. Registration number: Y2024980003501 |